Market Cap 21.01B
Revenue (ttm) 15.83B
Net Income (ttm) -119.55M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -0.76%
Debt to Equity Ratio 1.34
Volume 1,863,800
Avg Vol 5,939,378
Day's Range N/A - N/A
Shares Out 287.72M
Stochastic %K 54%
Beta 0.96
Analysts Strong Sell
Price Target $90.83

Company Profile

EchoStar Corporation, together with its subsidiaries, provides networking technologies and services in the United States and internationally. It operates through four segments: Pay-TV, Retail Wireless, 5G Network Deployment, Broadband and Satellite Services. The Pay-TV segment offers a direct broadcast and fixed satellite services; designs, develops, and distributes receiver system; and provides digital broadcast operations, including satellite uplinking/downlinking, transmission and, other serv...

Industry: Telecom Services
Sector: Communication Services
Phone: 303 723 1000
Address:
9601 South Meridian Boulevard, Englewood, United States
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 7:55 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SATS Current Share Price: $73.98 Contracts: $SATS December 18, 2026 $80 Calls Scale in: $14.58- $17.82 Scale out: $22.68-$29.16 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
FRAGMENTS
FRAGMENTS Oct. 24 at 3:39 PM
0 · Reply
FRAGMENTS
FRAGMENTS Oct. 24 at 1:02 PM
$SATS DEEP VALUE REPORT — Cable One (CABO) is live. 🚀 We priced it like a control buyer, not off GAAP noise. Hidden Asset. Cash Flow. Catalyst. Our grid says $565$960/sh on sober 2025 multiples — the screen disagrees… for now. ⏳If you wait for the press release, you’ll pay the re-rate. 🔒 Full $/share matrix, catalyst checklist, and add/trim rules→ https://cundilldeepvalue.substack.com/p/cable-one-nyse-cabo-deep-value-research $TDS $USM $TMUS $BAC
0 · Reply
BostonNorth
BostonNorth Oct. 23 at 2:04 PM
$SPRY Sustained high off-exchange (ATS) trading activity and unusual price behavior between June 30 and September 19, 2025, that appear inconsistent with fair and transparent market dynamics. Summary of Findings (refer to volume table below) Between June 30 – September 19, 2025, weekly off-exchange volume rose from 1.99 million to 3.51 million shares, averaging ≈30% of total trading. During this same period, total market volume increased approximately 2.5×, while the share price declined from $17.50 to $9.79 (−44%). The consistent 25–32% dark-pool share of total trading is abnormally high for a small-cap biotech, suggesting liquidity routing away from lit exchanges and potential impairment of transparent price discovery. Key Market Events and Catalysts Despite multiple major global milestones and value-enhancing developments, SPRY’s share price continued to decline during a period of elevated off-exchange trading: 1) June 2025 – EURneffy® 2 mg launched in Germany by ALK-Abelló, marking the first commercial rollout of ARS Pharmaceuticals’ intranasal epinephrine treatment in Europe. 2)July 18, 2025 – The U.K. formally approved EURneffy® (adrenaline nasal spray) as the first and only needle-free emergency treatment for anaphylaxis, representing a major European regulatory achievement. 3)September 19, 2025 – Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Neffy, ARS Pharmaceuticals’ intranasal epinephrine product, establishing its first regulatory authorization in Asia. 4)September 29, 2025 – The company announced $250 million in non-dilutive funding, materially strengthening its financial position without issuing new equity. 5)October 8, 2025 – The European Patent Office confirmed Neffy’s patent protection through 2039 across more than 30 European countries, securing long-term exclusivity in key markets. Each of these catalysts would typically drive higher investor confidence and support price appreciation. However, the data show increasing total and dark-pool volumes during a continuing price decline — signaling liquidity absorption and muted price discovery. If upcoming November earnings is a beat coupled with XUS approvals (Canada, New Zealand & Australia) all but Australia expected before year end…combined with lower off exchange trading. Consider this an $RKLB rocket ship ready to take off to another atmosphere. Lol. In all seriousness in my opinion only, the recent dip is a blessing for anyone that believes in the next EpiPen first and only needle free alternative Neffy (just launched worldwide ) and hives treatment (currently in under the radar phase two trials)! This could be the next red hot sector similar to $GSAT $ASTS $RKLB $SATS Good luck to all and not financial advice.
4 · Reply
prismmarketview
prismmarketview Oct. 22 at 2:29 PM
(NASDAQ: $SATS) Hughes is expanding its aviation, space, and defense portfolio with the acquisition of Anderson Connectivity. The deal adds advanced aerospace engineering talent and establishes a new innovation hub in Melbourne, FL. https://prismmarketview.com/hughes-expands-aerospace-capabilities-with-acquisition-of-anderson-connectivity/
0 · Reply
SpaceInvesting
SpaceInvesting Oct. 22 at 12:48 PM
News: Hughes $SATS Announces Acquisition of Anderson Connectivity for an Undisclosed Amount https://ir.echostar.com/news-releases/news-release-details/hughes-expands-aviation-space-and-defense-expertise-strategic
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 10:42 AM
Enter: $SATS NOV 14 2025 $76 CALLS Buy in Price: $5.03 - $5.28 Take Profit: $9.00 Stop Bleeding: $4.43 ROI Potential: 79% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
OptionRunners
OptionRunners Oct. 20 at 6:55 PM
Quick pop in $SATS to new highs $74+
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 20 at 6:20 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SATS Current Share Price: $72.38 Contracts: $SATS December 18, 2026 $80 Calls Scale in: $14.33- $17.52 Scale out: $22.29-$28.67 Can Easily Capture: 60% ROI Blended DTE: 425 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 1:25 PM
Enter: $SATS NOV 14 2025 $82 CALLS Buy in Price: $2.33 - $2.35 Take Profit: $5.03 Stop Bleeding: $2.05 ROI Potential: 116% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
Latest News on SATS
EchoStar: A Strong Buy On The Back Of A Landmark SpaceX Deal

Sep 10, 2025, 10:34 AM EDT - 6 weeks ago

EchoStar: A Strong Buy On The Back Of A Landmark SpaceX Deal


What's Next After EchoStar's 200% Surge?

Sep 10, 2025, 6:45 AM EDT - 6 weeks ago

What's Next After EchoStar's 200% Surge?


EchoStar Stock Soars on SpaceX Spectrum Deal

Sep 8, 2025, 4:36 PM EDT - 6 weeks ago

EchoStar Stock Soars on SpaceX Spectrum Deal


Top Stock Movers Now: EchoStar, Robinhood, T-Mobile, and More

Sep 8, 2025, 12:20 PM EDT - 6 weeks ago

Top Stock Movers Now: EchoStar, Robinhood, T-Mobile, and More


SpaceX to Buy EchoStar Spectrum for $17B

Sep 8, 2025, 12:03 PM EDT - 6 weeks ago

SpaceX to Buy EchoStar Spectrum for $17B


MDA SPACE PROVIDES UPDATE ON ECHOSTAR CONTRACT

Sep 8, 2025, 6:44 AM EDT - 6 weeks ago

MDA SPACE PROVIDES UPDATE ON ECHOSTAR CONTRACT


EchoStar to sell spectrum licenses to SpaceX for $17 billion

Sep 8, 2025, 6:43 AM EDT - 6 weeks ago

EchoStar to sell spectrum licenses to SpaceX for $17 billion


$4.99 Gets You the Games on Sling TV. Not the Gimmicks.

Sep 2, 2025, 8:02 AM EDT - 7 weeks ago

$4.99 Gets You the Games on Sling TV. Not the Gimmicks.


Disney Sues Sling TV Over Day Passes

Aug 27, 2025, 3:25 PM EDT - 2 months ago

Disney Sues Sling TV Over Day Passes

DIS


These Analysts Boost Their Forecasts On EchoStar

Aug 27, 2025, 2:16 PM EDT - 2 months ago

These Analysts Boost Their Forecasts On EchoStar


EchoStar: Is SATS Stock A Buy After 70% Rise?

Aug 27, 2025, 9:15 AM EDT - 2 months ago

EchoStar: Is SATS Stock A Buy After 70% Rise?


AT&T to Buy Spectrum Licenses From EchoStar for $23 Billion

Aug 26, 2025, 3:21 PM EDT - 2 months ago

AT&T to Buy Spectrum Licenses From EchoStar for $23 Billion

T


LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 24 at 7:55 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SATS Current Share Price: $73.98 Contracts: $SATS December 18, 2026 $80 Calls Scale in: $14.58- $17.82 Scale out: $22.68-$29.16 Can Easily Capture: 60% ROI Blended DTE: 421 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
FRAGMENTS
FRAGMENTS Oct. 24 at 3:39 PM
0 · Reply
FRAGMENTS
FRAGMENTS Oct. 24 at 1:02 PM
$SATS DEEP VALUE REPORT — Cable One (CABO) is live. 🚀 We priced it like a control buyer, not off GAAP noise. Hidden Asset. Cash Flow. Catalyst. Our grid says $565$960/sh on sober 2025 multiples — the screen disagrees… for now. ⏳If you wait for the press release, you’ll pay the re-rate. 🔒 Full $/share matrix, catalyst checklist, and add/trim rules→ https://cundilldeepvalue.substack.com/p/cable-one-nyse-cabo-deep-value-research $TDS $USM $TMUS $BAC
0 · Reply
BostonNorth
BostonNorth Oct. 23 at 2:04 PM
$SPRY Sustained high off-exchange (ATS) trading activity and unusual price behavior between June 30 and September 19, 2025, that appear inconsistent with fair and transparent market dynamics. Summary of Findings (refer to volume table below) Between June 30 – September 19, 2025, weekly off-exchange volume rose from 1.99 million to 3.51 million shares, averaging ≈30% of total trading. During this same period, total market volume increased approximately 2.5×, while the share price declined from $17.50 to $9.79 (−44%). The consistent 25–32% dark-pool share of total trading is abnormally high for a small-cap biotech, suggesting liquidity routing away from lit exchanges and potential impairment of transparent price discovery. Key Market Events and Catalysts Despite multiple major global milestones and value-enhancing developments, SPRY’s share price continued to decline during a period of elevated off-exchange trading: 1) June 2025 – EURneffy® 2 mg launched in Germany by ALK-Abelló, marking the first commercial rollout of ARS Pharmaceuticals’ intranasal epinephrine treatment in Europe. 2)July 18, 2025 – The U.K. formally approved EURneffy® (adrenaline nasal spray) as the first and only needle-free emergency treatment for anaphylaxis, representing a major European regulatory achievement. 3)September 19, 2025 – Japan’s Ministry of Health, Labour and Welfare (MHLW) approved Neffy, ARS Pharmaceuticals’ intranasal epinephrine product, establishing its first regulatory authorization in Asia. 4)September 29, 2025 – The company announced $250 million in non-dilutive funding, materially strengthening its financial position without issuing new equity. 5)October 8, 2025 – The European Patent Office confirmed Neffy’s patent protection through 2039 across more than 30 European countries, securing long-term exclusivity in key markets. Each of these catalysts would typically drive higher investor confidence and support price appreciation. However, the data show increasing total and dark-pool volumes during a continuing price decline — signaling liquidity absorption and muted price discovery. If upcoming November earnings is a beat coupled with XUS approvals (Canada, New Zealand & Australia) all but Australia expected before year end…combined with lower off exchange trading. Consider this an $RKLB rocket ship ready to take off to another atmosphere. Lol. In all seriousness in my opinion only, the recent dip is a blessing for anyone that believes in the next EpiPen first and only needle free alternative Neffy (just launched worldwide ) and hives treatment (currently in under the radar phase two trials)! This could be the next red hot sector similar to $GSAT $ASTS $RKLB $SATS Good luck to all and not financial advice.
4 · Reply
prismmarketview
prismmarketview Oct. 22 at 2:29 PM
(NASDAQ: $SATS) Hughes is expanding its aviation, space, and defense portfolio with the acquisition of Anderson Connectivity. The deal adds advanced aerospace engineering talent and establishes a new innovation hub in Melbourne, FL. https://prismmarketview.com/hughes-expands-aerospace-capabilities-with-acquisition-of-anderson-connectivity/
0 · Reply
SpaceInvesting
SpaceInvesting Oct. 22 at 12:48 PM
News: Hughes $SATS Announces Acquisition of Anderson Connectivity for an Undisclosed Amount https://ir.echostar.com/news-releases/news-release-details/hughes-expands-aviation-space-and-defense-expertise-strategic
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 21 at 10:42 AM
Enter: $SATS NOV 14 2025 $76 CALLS Buy in Price: $5.03 - $5.28 Take Profit: $9.00 Stop Bleeding: $4.43 ROI Potential: 79% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
OptionRunners
OptionRunners Oct. 20 at 6:55 PM
Quick pop in $SATS to new highs $74+
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 20 at 6:20 PM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SATS Current Share Price: $72.38 Contracts: $SATS December 18, 2026 $80 Calls Scale in: $14.33- $17.52 Scale out: $22.29-$28.67 Can Easily Capture: 60% ROI Blended DTE: 425 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 20 at 1:25 PM
Enter: $SATS NOV 14 2025 $82 CALLS Buy in Price: $2.33 - $2.35 Take Profit: $5.03 Stop Bleeding: $2.05 ROI Potential: 116% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 18 at 8:58 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SATS Current Share Price: $72.33 Contracts: $SATS December 18, 2026 $80 Calls Scale in: $15.48- $18.92 Scale out: $24.08-$30.96 Can Easily Capture: 60% ROI Blended DTE: 427 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
OptionRunners
OptionRunners Oct. 17 at 7:39 PM
Took some $SATS lotto calls
0 · Reply
OptionRunners
OptionRunners Oct. 17 at 4:45 PM
$SATS Trader sold (to close) the October 17th $50 calls (ITM) 5,000 times for $22.24 and bought (to open) the December 19th $50 calls 6,000 times for $23.26. The trader is rolling/adjusting the calls out for a $2.8M debit.
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 17 at 2:36 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SATS Current Share Price: $74.85 Contracts: $SATS December 18, 2026 $80 Calls Scale in: $14.92- $18.23 Scale out: $23.20-$29.84 Can Easily Capture: 60% ROI Blended DTE: 428 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
QuantInsider
QuantInsider Oct. 17 at 2:08 AM
$SATS saw some interesting action today Even with a 3.37% drop and 5.46% down this week There was a $4.89M sweep in 10/31 $60 ITM calls That's 3,864 contracts at the ask with OI at zero Looks like some aggressive dip-buying It's fighting a pretty strong downtrend Bullish flow is there I'd wait for price stabilization before jumping in Caution is key until things settle a bit
0 · Reply
MoneyGroupLLC
MoneyGroupLLC Oct. 17 at 12:33 AM
Enter: $SATS NOV 07 2025 $75 CALLS Buy in Price: $4.80 - $5.20 Take Profit: $11.80 Stop Bleeding: $4.58 ROI Potential: 127% Exit Within: 3 Weeks https://moneygroup.us/alerts
0 · Reply
AbovetheGreenLine
AbovetheGreenLine Oct. 16 at 7:45 PM
EchoStar Holding $SATS is Don't Take a Loss! https://abovethegreenline.com/wp-content/uploads/2021/01/ST-1.jpg https://zpr.io/AzBms4kxPBa4
0 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Oct. 16 at 12:10 PM
$SATS if/when they get the expected full allotment of SpaceX shares, this should literally take off
1 · Reply
THE_Monkey_Banana_Genius
THE_Monkey_Banana_Genius Oct. 16 at 12:03 PM
$SATS long once again 74s
0 · Reply
MRSTOCKTWEETS
MRSTOCKTWEETS Oct. 15 at 6:40 PM
$SATS when they filling for BK?
0 · Reply
LiquidThetaLEAPS
LiquidThetaLEAPS Oct. 14 at 11:44 AM
LiquidTheta® LEAPS LIVE Actionable Alert Asset: $SATS Current Share Price: $74.00 Contracts: $SATS December 18, 2026 $80 Calls Scale in: $15.48- $18.92 Scale out: $24.08-$30.96 Can Easily Capture: 60% ROI Blended DTE: 431 Days | Join Elites here: https://liquidtheta.com/options
0 · Reply
fastpaymakesfastfriends
fastpaymakesfastfriends Oct. 13 at 2:29 PM
$SATS at leadt 100
1 · Reply